Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1

Conditions

Breast Neoplasms 3Neoplasms 2Motor Activity 2Lymphoma 2Anxiety Disorders 2Weight Gain 1Vomiting 1Triple Negative Breast Neoplasms 1Treatment Adherence and Compliance 1Recurrence 1Obesity 1Nausea 1Lymphoma, Large B-Cell, Diffuse 1Lymphedema 1Gastrointestinal Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Weights and Measures × Clear all
NCT04453072 2026-05-11

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

Jonsson Comprehensive Cancer Center

Phase NA Recruiting
20 enrolled
Other

Neoplasms, Obesity

NCT03330145 2021-07-26

CAPS

University Hospital, Toulouse

Phase NA Completed
38 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡